Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1420 ARTÍCULOS , VIENDO DEL 166 AL 180

Diagnostic value of blood p-tau subtypes in Alzheimer's disease progression and pathology: systematic review and meta-analysis

Zhang P, Huang D, Lu X, Zhong H, Liu C, Liu H, Duan X, Wu J.

Eur Arch Psychiatry Clin Neurosci. 2026 Oct;276(7):3329-3341. doi: 10.1007/s00406-026-02353-4. Epub 2026 Aug 22.

Prion disease mimicking rapidly progressive Alzheimer disease: case series and systematic review

Elgenidi A, Shir D, Piura YD, Sokol LL, Duara R, Lachner C, Day GS.

J Neurol. 2026 Sep 7;273(10):565. doi: 10.1007/s00415-026-14087-3.

More efficient screening for preclinical Alzheimer's clinical trials using mixture of experts

Langford O, Raman R, Aisen P, Sperling R, Johnson K, Molina-Henry D, Sachdev P, Li D, Jimenez-Maggiora GA, Johnson SC, Braunstein JB, Birkenbihl C, Cuppels M, Buckley RF, Rissman RA, Donohue MC.

Alzheimers Dement. 2026 Sep;22(9):e71681. doi: 10.1002/alz.71681.

Peripheral-central inflammatory crosstalk in Alzheimer's disease: immunometabolic functions of circulating soluble metabolites under dynamic blood-brain barrier states

Song N, Xing H, Liu F, Xi W.

Front Immunol. 2026 Aug 28;17:1939482. doi: 10.3389/fimmu.2026.1939482. eCollection 2026.

Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes

Hey JA, Abushakra S, Power A, Watson D, Porsteinsson A, Sabbagh M, MacSweeney E, Cohen S, Boada M, Doraiswamy PM, Elahi FM, Rissman RA, Liang E, Flint S, Hristova E, Kesslak P, McLaine R, Albayrak A, Schaefer JF, Yu JY, Tolar L, Tolar M.

Drugs. 2026 Oct;86(10):1705-1721. doi: 10.1007/s40265-026-02381-3. Epub 2026 Sep 1.

Concordance between plasma biomarkers of phosphorylated tau and tau-PET: A narrative review

Van Houwelingen AS, Vernooij MW, Vermeiren MR, Ossenkoppele R, Van De Giessen E, Seelaar H, Neitzel J.

J Alzheimers Dis. 2026 Sep;113(2):561-577. doi: 10.1177/13872877261468708. Epub 2026 Aug 8.

Small nucleolar RNAs: Emerging therapeutic and diagnostic frontiers in Alzheimer's disease

Sharma T, Sharma P, Bashir B, Singh SK, Vishwas S.

Drug Discov Today. 2026 Sep;31(5):104771. doi: 10.1016/j.drudis.2026.104771. Epub 2026 Aug 14.

Diagnostic accuracy of plasma p-tau217 against amyloid PET: A meta-analysis of technical platform variability and ratio versus single marker comparisons

Yuan C, Zhang H, Chen X, Zhu L, Wang Z, Wang Y, Ge S.

Neurol Sci. 2026 Aug 27;47(9):738. doi: 10.1007/s10072-026-09322-8.

Alzheimer's Disease in the Era of Geroscience: Mechanisms, Biomarkers, and Therapeutic Prospects

Chmielewski PP.

Cells. 2026 Sep 2;15(17):1599. doi: 10.3390/cells15171599.

Operationalizing Alzheimer's disease trials in the era of targeted therapies

Pillai JA, Alladi S, Appleby BS, Brosch JR, Frederiksen KS, Galasko D, Lopez OL, Leverenz JB, Saykin AJ, Schott JM, Seshadri S, Tousi B, Wolk DA.

Alzheimers Dement. 2026 Sep;22(9):e71829. doi: 10.1002/alz.71829.

Exosomes in Alzheimer's Disease: From Pathological Mechanisms to Biomarker Potential and Therapeutic Applications

Aydın AC.

Mol Neurobiol. 2026 Sep 17;63(1):904. doi: 10.1007/s12035-026-06191-2.

Beyond Amyloid: Systemic and Brain Frailty as Determinants of Response to Anti-Amyloid Therapy in Alzheimer's Disease-A Conceptual Review

Rus Prelog P, Zupan M, Šabović M, Frol S, Kramberger MG.

Medicina (Kaunas). 2026 Aug 2;62(8):1489. doi: 10.3390/medicina62081489.

Synapse-associated neuropathological markers in Alzheimer's disease

Barrantes FJ.

Brain. 2026 Sep 7;149(9):2923-2935. doi: 10.1093/brain/awag117.

Neuroinflammation in neurodegenerative diseases: pathogenic pathways and emerging pharmacotherapeutic targets in Alzheimer's and Parkinson's disease

Kumar RR, Kamaljeet, Kosey S.

Inflammopharmacology. 2026 Jul 7. doi: 10.1007/s10787-026-02325-z. Online ahead of print.

Unlocking new uses: The promise of antidepressants in treating Alzheimer's and Parkinson's through Neuroinflammation modulation

Abbaszadeh F, Amini NB, Davoody S, Rezaei M, Ghasemi R, Javadpour P.

Prog Neuropsychopharmacol Biol Psychiatry. 2026 Jul 20;149:111848. doi: 10.1016/j.pnpbp.2026.111848. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias